COVID-19 trials registries data warehouse

 Return to trial list

Trial - IRCT20140818018842N23


Column Value
Trial registration number IRCT20140818018842N23
Full text link
Last imported at : April 3, 2022, 4:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

First author
Last imported at : April 3, 2022, 4:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Seied Asadollah Mousavi

Contact
Last imported at : April 3, 2022, 4:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

barkhordarm.n@gmail.com

Registration date
Last imported at : April 3, 2022, 4:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

2022-04-03

Recruitment status
Last imported at : Feb. 3, 2023, 8:23 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Completed

Study design
Last imported at : Aug. 21, 2022, 10 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

nonRCT

Allocation
Last imported at : Aug. 21, 2022, 10 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Non-randomized

Design
Last imported at : Aug. 21, 2022, 10 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Parallel

Masking
Last imported at : April 3, 2022, 4:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Open label

Center
Last imported at : April 3, 2022, 4:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

single-center

Study aim
Last imported at : April 3, 2022, 4:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Prevention

Inclusion criteria
Last imported at : April 3, 2022, 4:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

َAll autologous stem cell transplantation Age >=18

Exclusion criteria
Last imported at : April 3, 2022, 4:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

patients who received Rituximab during the past six months. Patients who do not consent to vaccination after transplantation

Number of arms
Last imported at : Aug. 21, 2022, 10 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

2

Funding
Last imported at : April 3, 2022, 4:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Tehran University of Medical Sciences

Inclusion age min
Last imported at : April 3, 2022, 4:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

18

Inclusion age max
Last imported at : April 3, 2022, 4:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

70

Countries
Last imported at : April 3, 2022, 4:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Iran

Type of patients
Last imported at : April 3, 2022, 4:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

High risk patients

Severity scale
Last imported at : April 3, 2022, 4:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

N/A

Total sample size
Last imported at : Aug. 21, 2022, 10 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

124

primary outcome
Last imported at : April 3, 2022, 4:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

SARS-CoV-2 specific IgG (anti-S1) titer

Notes
Last imported at : April 3, 2022, 4:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Phase
Last imported at : April 3, 2022, 4:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Phase 2

Arms
Last imported at : Aug. 21, 2022, 10 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

[{"arm_notes": "3 months post-transplant", "treatment_id": 2438, "treatment_name": "Pastocovac", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "healthy people", "treatment_id": 2438, "treatment_name": "Pastocovac", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}]